A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Howard M Lazarus, MD, FCCP
Altavant Sciences GmbH
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
64 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ordensklinikum Linz Gmbh Elisabethinen
Linz, Upper Austria, Austria
- Akh- Wien, Medizinische Univsersität Wien
Vienna, Austria
- Hôpital Erasme
Brussels, Brussels Capital, Belgium
- Uz Leuven - Campus Gasthuisberg - Pneumologie
Leuven, Vlaams Brabant, Belgium
- University Clinical Centre of the Republic of Srpska
Banja Luka, Bosnia and Herzegovina
- University Clinical Hospital Mostar
Mostar, Bosnia and Herzegovina
- University Mhat "sv. Anna"
Sofia, Sofia-Grad, Bulgaria
- Peter Lougheed Centre
Calgary, Alberta, Canada
- London Health Sciences Centre - Victoria Hospital
London, Ontario, Canada
- University Health Network, Toronto General Hospital
Toronto, Ontario, Canada
- Sir Mortimer B. Davis Jewish General Hospital
Montreal, Quebec, Canada
- Fakultni Nemocnice Olomouc
Olomouc, Czechia
- Vseobecna Fakultni Nemocnice V Praze
Prague, Czechia
- Centre Hospitalier Universitaire (chu) de Caen - Hopital Cote de Nacre
Caen, Calvados, France
- Groupement Hospitalier Est
Lyon, Rhône, France
- Chu de Bicetre
Le Kremlin-Bicêtre, Val-de-Marne, France
- Chu de Saint-Etienne - Hopital Nord
Saint-Etienne, France
- Universitätsklinikum Giessen Und Marburg
Giessen, Germany
- Umberto I Policlinico Di Roma, Università la Sapienza
Rome, Roma, Italy
- Aou S.Martino, Irccs, Ist-Istituto Nazionale Ricerca Sul Can
Genova, Italy
- Irccs Policlinico San Matteo, Università Degli Studi Di Pavi
Pavia, Italy
- P.Stradina Clinical University Hospital
Riga, Latvia
- Spitalul Clinic Republican
Chisinau, Moldova
- Wojewodzki Specjalistyczny Szpital Im. Dr Wl. Bieganskiego
Lodz, Lódzkie, Poland
- Uniwersytecki Szpital Kliniczny W Bialymstoku
Bialystok, Poland
- Samodzielny Publiczny Szpital Kliniczny Nr 4 W Lublinie
Lublin, Poland
- Europejskie Centrum Zdrowia Otwock Szpital Im Fryderyka Chopina
Otwock, Poland
- Institute for Cardiovascular Diseases of Vojvodina
Kamenitz, Vojvodina, Serbia
- Institute for Pulmonary Diseases of Vojvodina
Kamenitz, Vojvodina, Serbia
- Clinical Center of Serbia
Belgrade, Serbia
- Hospital Clinic de Barcelona
Barcelona, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Dnipropetrovsk Regional Clinical Diagnostic Center
Dnipro, Dnipropetrovsk Oblast, Ukraine
- Nats Naukovyi Tsentr Amn Ukrainy
Kyiv, Ukraine
- Royal Brompton Hospital
London, United Kingdom
- Royal Free London Nhs Foundation Trust
London, United Kingdom
- Arizona Pulmonary Specialists
Phoenix, Arizona, United States
- University of California San Diego Health Sciences
La Jolla, California, United States
- Ronald Reagan Ucla Medical Center
Los Angeles, California, United States
- Va Greater la Healthcare System/ucla
Los Angeles, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Mar 2021
- Primary completion
- 5 Jun 2023
- Completion
- 28 Aug 2023
- Last update posted
- 4 Jun 2025
- Registered enrollment
- 108
- Registry id
- NCT04712669
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.